{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:32:03Z","timestamp":1792794723316,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a rare heterogenous genetic or acquired hyperinflammatory syndrome associated with a high degree of morbidity and mortality. HLH has clinical manifestations related to abnormal prolonged activation of T lymphocytes and macrophages with an excess of proinflammatory cytokines. The main causes of secondary HLH are malignancies and infectious diseases.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The patient was a 54-year-old man, originally from Eastern Africa, who had lived in Northern Europe for 30\u00a0years. Here we describe the clinical features, laboratory parameters, diagnostic workup, management and outcome data of a previously healthy 54-year-old man diagnosed with HLH secondary to tuberculosis. The patient was initially treated for a community-acquired pneumonia. He developed multiorgan failure with acute respiratory distress syndrome, hypertransaminasemia, and kidney and bone marrow dysfunction. The clinical course together with a simultaneous increase in serum ferritin raised the suspicion of HLH. The patient fulfilled seven out of eight diagnostic criteria for HLH. A thorough diagnostic workup with respect to HLH and a potential underlying disease was initiated. Cultivation of bronchoalveolar lavage fluid, stool and urine, and polymerase chain reaction of epithelioid cell granulomas in the bone marrow were all positive for <jats:italic>Mycobacterium tuberculosis<\/jats:italic>. He was treated for both HLH and tuberculosis, and he survived without any sequelae.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We present one of few published cases of a patient who\u00a0survived HLH triggered by miliary tuberculosis. The current case illustrates the need for awareness of these two diagnoses, and the timely initiation of specific and supportive treatment to reduce mortality.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-020-02555-x","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:08:16Z","timestamp":1605053296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hemophagocytic lymphohistiocytosis and miliary tuberculosis in a previously healthy individual: a case report"],"prefix":"10.1186","volume":"14","author":[{"given":"Linn Hereide","family":"Trovik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sandnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"Blomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild","family":"Holmaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymen Bushra","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor Henrik Anderson","family":"Tvedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Vintermyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-8411","authenticated-orcid":false,"given":"H\u00e5kon","family":"Reikvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"2555_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1182\/asheducation-2015.1.177","volume":"2015","author":"CE Allen","year":"2015","unstructured":"Allen CE, McClain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. Hematol Am Soc Hematol Educ Program. 2015;2015:177\u201382.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"19","key":"2555_CR2","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908\u201314.","journal-title":"Blood"},{"issue":"4","key":"2555_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","volume":"28","author":"GE Janka","year":"2014","unstructured":"Janka GE, Lehmberg K. Hemophagocytic syndromes\u2014an update. Blood Rev. 2014;28(4):135\u201342.","journal-title":"Blood Rev"},{"issue":"2","key":"2555_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/bjh.15274","volume":"182","author":"RA Marsh","year":"2018","unstructured":"Marsh RA, Haddad E. How I treat primary haemophagocytic lymphohistiocytosis. Br J Haematol. 2018;182(2):185\u201399.","journal-title":"Br J Haematol"},{"issue":"3","key":"2555_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/bjh.12138","volume":"160","author":"K Lehmberg","year":"2013","unstructured":"Lehmberg K, Ehl S. Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. Br J Haematol. 2013;160(3):275\u201387.","journal-title":"Br J Haematol"},{"issue":"22","key":"2555_CR6","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1182\/blood-2011-07-370148","volume":"118","author":"K Zhang","year":"2011","unstructured":"Zhang K, Jordan MB, Marsh RA, Johnson JA, Kissell D, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011;118(22):5794\u20138.","journal-title":"Blood"},{"issue":"3","key":"2555_CR7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jaip.2018.11.050","volume":"7","author":"KA Risma","year":"2019","unstructured":"Risma KA, Marsh RA. Hemophagocytic lymphohistiocytosis: clinical presentations and diagnosis. J Allergy Clin Immunol Pract. 2019;7(3):824\u201332.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"2555_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.amjmed.2014.04.034","volume":"127","author":"S Riviere","year":"2014","unstructured":"Riviere S, Galicier L, Coppo P, Marzac C, Aumont C, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med. 2014;127(11):1118\u201325.","journal-title":"Am J Med"},{"issue":"11","key":"2555_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.15585\/mmwr.mm6811a3","volume":"68","author":"A MacNeil","year":"2019","unstructured":"MacNeil A, Glaziou P, Sismanidis C, Maloney S, Floyd K. Global epidemiology of tuberculosis and progress toward achieving global targets\u20142017. MMWR Morb Mortal Wkly Rep. 2019;68(11):263\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2555_CR10","unstructured":"Global tuberculosis report 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"7","key":"2555_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S1473-3099(06)70524-2","volume":"6","author":"PK Brastianos","year":"2006","unstructured":"Brastianos PK, Swanson JW, Torbenson M, Sperati J, Karakousis PC. Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis. 2006;6(7):447\u201354.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2555_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jmii.2011.01.027","volume":"44","author":"YT Tseng","year":"2011","unstructured":"Tseng YT, Sheng WH, Lin BH, Lin CW, Wang JT, et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011;44(3):191\u20137.","journal-title":"J Microbiol Immunol Infect"},{"key":"2555_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.puhe.2019.10.022","volume":"180","author":"N Riccardi","year":"2020","unstructured":"Riccardi N, Pontarelli A, Alagna R, Saderi L, Ferrarese M, et al. Epidemiology and treatment outcome of MDR and pre-XDR TB in international migrants at two reference centers in the North of Italy: a cross-sectional study coordinated by Stop TB Italia Onlus. Public Health. 2020;180:17\u201321.","journal-title":"Public Health"},{"issue":"2","key":"2555_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2555_CR15","first-page":"61","volume":"79","author":"B Blomberg","year":"2001","unstructured":"Blomberg B, Spinaci S, Fourie B, Laing R. The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis. Bull World Health Organ. 2001;79(1):61\u20138.","journal-title":"Bull World Health Organ"},{"issue":"23","key":"2555_CR16","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Rosee","year":"2019","unstructured":"La Rosee P, Horne A, Hines M, von Bahr GT, Machowicz R, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465\u201377.","journal-title":"Blood"},{"issue":"5446","key":"2555_CR17","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","volume":"286","author":"SE Stepp","year":"1999","unstructured":"Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286(5446):1957\u20139.","journal-title":"Science"},{"issue":"3","key":"2555_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.20140964","volume":"212","author":"MR Jenkins","year":"2015","unstructured":"Jenkins MR, Rudd-Schmidt JA, Lopez JA, Ramsbottom KM, Mannering SI, et al. Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212(3):307\u201317.","journal-title":"J Exp Med"},{"key":"2555_CR19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1182\/asheducation-2013.1.605","volume":"2013","author":"GE Janka","year":"2013","unstructured":"Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematol Am Soc Hematol Educ Program. 2013;2013:605\u201311.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1 Suppl","key":"2555_CR20","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.bbmt.2009.11.014","volume":"16","author":"A Filipovich","year":"2010","unstructured":"Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant. 2010;16(1 Suppl):S82\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2555_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3324\/haematol.2018.198655","volume":"104","author":"JH Yoon","year":"2019","unstructured":"Yoon JH, Park SS, Jeon YW, Lee SE, Cho BS, et al. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy. Haematologica. 2019;104(2):269\u201376.","journal-title":"Haematologica"},{"issue":"17","key":"2555_CR22","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1002\/cncr.30826","volume":"123","author":"N Daver","year":"2017","unstructured":"Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, et al. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017;123(17):3229\u201340.","journal-title":"Cancer"},{"issue":"10229","key":"2555_CR23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033\u20134.","journal-title":"Lancet"},{"issue":"5","key":"2555_CR24","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1086\/516972","volume":"25","author":"JA Arranz Caso","year":"1997","unstructured":"Arranz Caso JA, Garcia Tena J, Llorens MM, Moreno R. High serum ferritin concentration in an AIDS patient with miliary tuberculosis. Clin Infect Dis. 1997;25(5):1263\u20134.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2555_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.5588\/ijtld.16.0515","volume":"21","author":"SF Weber","year":"2017","unstructured":"Weber SF, Belard S, Rai S, Reddy R, Belurkar S, et al. Immune thrombocytopenia secondary to tuberculosis: a case and review of literature. Int J Tuberc Lung Dis. 2017;21(4):466\u201370.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"16","key":"2555_CR26","doi-asserted-by":"publisher","first-page":"e6575","DOI":"10.1097\/MD.0000000000006575","volume":"96","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liang G, Qin H, Li Y, Zeng X. Tuberculosis-associated hemophagocytic lymphohistiocytosis with initial presentation of fever of unknown origin in a general hospital: an analysis of 8 clinical cases. Medicine (Baltimore). 2017;96(16):e6575.","journal-title":"Medicine (Baltimore)"},{"issue":"18","key":"2555_CR27","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMicm1910558","volume":"382","author":"M Kessler","year":"2020","unstructured":"Kessler M, Reinig E. HLH associated with disseminated tuberculosis. N Engl J Med. 2020;382(18):1749.","journal-title":"N Engl J Med"},{"issue":"25","key":"2555_CR28","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","volume":"130","author":"E Bergsten","year":"2017","unstructured":"Bergsten E, Horne A, Arico M, Astigarraga I, Egeler RM, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017;130(25):2728\u201338.","journal-title":"Blood"},{"issue":"1","key":"2555_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4049\/jimmunol.1302282","volume":"192","author":"TS Johnson","year":"2014","unstructured":"Johnson TS, Terrell CE, Millen SH, Katz JD, Hildeman DA, et al. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. J Immunol. 2014;192(1):84\u201391.","journal-title":"J Immunol"},{"issue":"17","key":"2555_CR30","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","volume":"118","author":"H Trottestam","year":"2011","unstructured":"Trottestam H, Horne A, Arico M, Egeler RM, Filipovich AH, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011;118(17):4577\u201384.","journal-title":"Blood"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02555-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-020-02555-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02555-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:32:55Z","timestamp":1605054775000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-020-02555-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2555"],"URL":"https:\/\/doi.org\/10.1186\/s13256-020-02555-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"assertion":[{"value":"7 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written consent was obtained from the patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"217"}}